MHC-II heterozygosity limits type 1 diabetes susceptibility through negative selection

Nat Immunol. 2023 Apr;24(4):573-574. doi: 10.1038/s41590-023-01446-9.
No abstract available

MeSH terms

  • Diabetes Mellitus, Type 1* / genetics
  • Disease Susceptibility
  • Heterozygote
  • Humans
  • Major Histocompatibility Complex